108 related articles for article (PubMed ID: 18652534)
21. APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians.
Valcke HS; Bernard NF; Bruneau J; Alary M; Tsoukas CM; Roger M
AIDS; 2006 Oct; 20(15):1984-6. PubMed ID: 16988524
[TBL] [Abstract][Full Text] [Related]
22. Natural resistance to HIV infection: The Vif-APOBEC interaction.
Malim MH
C R Biol; 2006 Nov; 329(11):871-5. PubMed ID: 17067930
[TBL] [Abstract][Full Text] [Related]
23. Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort.
Do H; Vasilescu A; Diop G; Hirtzig T; Heath SC; Coulonges C; Rappaport J; Therwath A; Lathrop M; Matsuda F; Zagury JF
J Infect Dis; 2005 Jan; 191(2):159-63. PubMed ID: 15609224
[TBL] [Abstract][Full Text] [Related]
24. Intensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain.
Feng Y; Chelico L
J Biol Chem; 2011 Apr; 286(13):11415-26. PubMed ID: 21300806
[TBL] [Abstract][Full Text] [Related]
25. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
Tiensiwakul P
Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
[TBL] [Abstract][Full Text] [Related]
26. APOBEC3B deletion impacts on susceptibility to acquire HIV-1 and its advancement among individuals in western India.
Singh H; Marathe SD; Nain S; Nema V; Ghate MV; Gangakhedkar RR
APMIS; 2016 Oct; 124(10):881-7. PubMed ID: 27522954
[TBL] [Abstract][Full Text] [Related]
27. Genetic association of IL-10 gene promoter polymorphism and HIV-1 infection in North Indians.
Chatterjee A; Rathore A; Sivarama P; Yamamoto N; Dhole TN
J Clin Immunol; 2009 Jan; 29(1):71-7. PubMed ID: 18683035
[TBL] [Abstract][Full Text] [Related]
28. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
[TBL] [Abstract][Full Text] [Related]
29. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
[TBL] [Abstract][Full Text] [Related]
30. Mannose-binding lectin (+54) exon-1 gene polymorphism influence human immunodeficiency virus-1 susceptibility in North Indians.
Chatterjee A; Rathore A; Yamamoto N; Dhole TN
Tissue Antigens; 2011 Jan; 77(1):18-22. PubMed ID: 20887383
[TBL] [Abstract][Full Text] [Related]
31. APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression.
Vázquez-Pérez JA; Ormsby CE; Hernández-Juan R; Torres KJ; Reyes-Terán G
Retrovirology; 2009 Mar; 6():23. PubMed ID: 19254362
[TBL] [Abstract][Full Text] [Related]
32. A new approach to an AIDS vaccine: creating antibodies to HIV vif will enable apobec3G to turn HIV-infection into a benign problem.
Jeffrey Fessel W
Med Hypotheses; 2005; 64(2):261-3. PubMed ID: 15607551
[TBL] [Abstract][Full Text] [Related]
33. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
[TBL] [Abstract][Full Text] [Related]
34. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.
Yu Q; König R; Pillai S; Chiles K; Kearney M; Palmer S; Richman D; Coffin JM; Landau NR
Nat Struct Mol Biol; 2004 May; 11(5):435-42. PubMed ID: 15098018
[TBL] [Abstract][Full Text] [Related]
35. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
[TBL] [Abstract][Full Text] [Related]
36. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.
Santa-Marta M; Aires da Silva F; Fonseca AM; Rato S; Goncalves J
Mol Immunol; 2007 Jan; 44(4):583-90. PubMed ID: 16580072
[TBL] [Abstract][Full Text] [Related]
38. Analysis of a biallelic polymorphism in the tumor necrosis factor alpha promoter and HIV type 1 disease progression.
Knuchel MC; Spira TJ; Neumann AU; Xiao L; Rudolph DL; Phair J; Wolinsky SM; Koup RA; Cohen OJ; Folks TM; Lal RB
AIDS Res Hum Retroviruses; 1998 Mar; 14(4):305-9. PubMed ID: 9519891
[TBL] [Abstract][Full Text] [Related]
39. Association of single nucleotide polymorphisms of APOBEC3G with susceptibility to HIV-1 infection and disease progression among men engaging in homosexual activity in northern China.
Li Q; Qiao Y; Zhang G; He N; Zhang X; Jia X; Sun H; Wang C; Xu L
Arch Virol; 2017 Jan; 162(1):259-268. PubMed ID: 27730383
[TBL] [Abstract][Full Text] [Related]
40. Human leukocyte antigen B distribution in HIV discordant cohort from India.
Chaudhari DV; Chavan VR; Ahir SP; Kerkar SC; Mehta PR; Mania-Pramanik J
Immunol Lett; 2013; 156(1-2):1-6. PubMed ID: 24029662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
